The Management and Prevention of Premalignant Penile Lesions

REFERENCES

• Jensen MS. Cancer of the penis in Denmark 1942 to 1962 (511 cases). Dan Med Bull 1977; 24: 66–72.
   PubMed Web of Science ®Google Scholar
• Young MJ, Reda DJ, Waters WB. Penile carcinoma: a twenty-five-year experience. Urology 1991; 38: 529–32.
   Google Scholar
• Taylor CA, Keller ML, Egan H. Advice from affected persons about living with human papillomavirus infec-tion. Image J Nurs Sch 1997; 29: 27–32.
   Google Scholar
• Maw RD, Reitano M, Roy M. An international survey of patients with genital warts; perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998; 9: 571–8.
   Google Scholar
• Gross GE, Tyring SK, von Krogh G, Barrasso R. External genitalia: treatment. In: Gross GE, Barrasso R, eds. Human papillomavirus infection. Berlin/Wies-baden: Ullstein Mosby, 1997: 365–76.
   Google Scholar
• Ferenzcy A, von Krogh G. External genital warts: current and new therapies. J Genital Infect Neoplasia 2000: 17–27.
   Google Scholar
• Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998; 47(RR-1): 1–1 1 1.
   Google Scholar
• Clinical Effectiveness Group (Association of Genitour-inary Medicine and the Medical Society for the Study of Venereal Diseases). UK National guideline for the management of anogenital warts. Sex Transm Infect 1999; 75 Suppl 1: S71–5.
   PubMedGoogle Scholar
• Cowen FM. Evidence-based medicine: an overview. Int J STD AIDS 1999; 10: 5–7.
   PubMed Web of Science ®Google Scholar
• Gross G, von Krogh G, Barrasso R. Genitoanal lesions. In: Gross G, von Krogh G, eds. Human papillomavirus infections in dermatovenereology. Boca Raton, FL: CRC Press, 1997: 389–416.
   Google Scholar
• Von Krogh G, Lacey CJN, Gross G, Barrasso R, Schneider A. European Course of HPV-associated pathology: Guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000: in press.
   Google Scholar
• Von Krogh G. Podophyllotoxin in serum: absorption subsequent to three-day repeated application of a 0.5% ethanol preparation on condylomata acuminata. Sex Transm Dis 1982; 9: 26–30.
   PubMed Web of Science ®Google Scholar
• Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134: 25–30.
   PubMed Web of Science ®Google Scholar
• Tyring SK, Arany I, Stanley MA, et al. A randomized, controlled, molecular study of condylomata acuminata clearance drug treatment with imiquimod. J Infect Dis 1998; 178: 551–5.
   PubMed Web of Science ®Google Scholar
• Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM. Treatment of genital warts with an immune-response modifier/imiquimod. J Am Acad Dermatol 1998; 38: 230–9.
   PubMed Web of Science ®Google Scholar
• Miller RL, Gerster if, Owens MA, et al. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacol 1999; 21: 1–14.
   PubMed Web of Science ®Google Scholar
• Pickering RW. Self-treatment of genital warts using Warticon (0.5% podophyllotoxin solution). Br J Sex Med 1989: 1–4.
   Google Scholar
• Von Krogh G. Penile condylomata acuminata: an experimental model for evaluation of topical treatment with 0.5-1.0% ethanolic preparations of podophyllo-toxin for three days. Sex Transm Dis 1981; 8: 179–84.
   Google Scholar
• Longstaff E, von Krogh G Condyloma eradication: self-therapy with 0.15% - 0.5% podophyllotoxin versus 20-25% podophyllin-an integrated safety assessment. 2000; in preparation.
   Google Scholar
• Mohanty KC. The cost effectiveness of treatment of genital warts with podophyllotoxin. Int J STD AIDS 1994; 5: 253–8.
   PubMed Web of Science ®Google Scholar
• Lacey C, Maw R, Kinghom GR, Fisk PG, et al. Randomised controlled and economic evaluation of patient-applied podophyllotoxin solution or cream or clinic-applied podophyllin in the treatment of genital warts. Br Med J 2000: in press.
   Google Scholar
• Mazurkiewicz W, Jablonska S. Clinical efficacy of Condyline (0.5% podophyllotoxin) solution and cream versus podophyllin in the treatment of external con-dylomata acuminata. J Dermatol Treatment 1990; 1: 123–5.
   Google Scholar
• Kinghom GR, McMillan A, Mulcahy F, Clarke S, Lacey C, Bingham JS. An open comparative study of the efficacy of 0.5% podophyllotoxin lotion and 25% podophyllin solution in the treatment of condylomata acuminata in males and females. Int J STD AIDS 1993; 4: 194–9.
   Google Scholar
• Von Krogh G, Szpak E, Andersson M, et al. Self-treatment using 0.25%-0.5% podophyllotoxin ethanol solutions against penile condylomata acuminata-a placebo-controlled comparative study. Genitourin Med 1994; 70: 105–9.
   Google Scholar
• Strand A, Brinkebom R-M, Siboulet A. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Geni-tourin Med 1995; 7: 387–90.
   Google Scholar
• Sand Peterson C, Agner T, Ottevanger V, et al. A single-blind study of podophyllotoxin cream 0.5% and podophyllotoxin solution 0.5% in male patients with genital warts. Genitourin Med 1995; 71: 391–2.
   Google Scholar
• Claesson U, Lassus A, Happonen H, et al. Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution. Int J STD AIDS 1996; 7: 429–34.
   PubMed Web of Science ®Google Scholar
• Gollnick H, Barasso R, Benninghoff B, et al. Safety and efficacy of imiquimod 5% cream in uncircumcised males with foreskin-associated genital warts. Poster #P711 at the 8th Congress of the European Academy of Dermatology and Venereology, Amsterdam, The Neth-erlands, September 29-October 3, 1999.
   Google Scholar
• Dretler SP, Klein I. The eradiction of intraurethral condylomata acuminata with 5-fluorouracil cream. J Urol 1975; 113: 195–7.
   PubMed Web of Science ®Google Scholar
• Wein AJ, Benson GS. Treatment of urethral condylo-mata acuminata with 5-FU cream. J Urol 1977; 9: 413–5.
   Google Scholar
• von Krogh G. 5-Fluoro-uracil cream in the successful treatment of therapeutically refactory condylomata acuminata of the urinary meatus. Acta Derm Venereol 1976; 56: 297–300.
   PubMed Web of Science ®Google Scholar
• Godley MJ, Bradbeer CS, Gellan M, et al. Cryotherapy compared with trichloracetic acid in treating genital warts. Genitourin Med 1987; 63: 390–2.
   PubMedGoogle Scholar
• Abdullah AN, Walzman M, Wade A. Treatment of external genital warts comparing cryotherapy (liquid nitrogen) and trichloracetic acid. Sex Transm Dis 1993; 20: 344–5.
   Google Scholar
• Cetti NE. Condyloma acuminatum of the urethra: problems in eradication. Br J Surg 1984; 71: 57–61.
   PubMed Web of Science ®Google Scholar
• Sand Petersen C, Weismann K. Quercetin and Kaem-pherol; an argument against the use of podophyllin? Genitourin Med 1995; 71: 92–3.
   PubMedGoogle Scholar
• Simmons PD, Thomson JPS. Scissors excision of penile warts: case report. Genitourin Med 1986; 62: 277–8.
   PubMedGoogle Scholar
• Ferenczy A, von Krogh G. External genital warts: current and new therapies. In: Monsonego J, ed. Paris: EUROGIN Scientific Publications, 2000: 21–8.
   Google Scholar
• Rylander E, Sjoberg I, Lilleborg S. Local anaesthesia of the genital mucosa with a lidocaine/prilocaine cream (EMLA6) for laser treatment of condylomata acumina-ta. A placebo-controlled study. Obstet Gynecol 1990; 75: 302–6.
   Google Scholar
• US Department of Health and Human Services, Agency for Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma. Rockville (MD): The Agency; 1993 Clinical Practice Guidelines No. 1. AHCPR Publication No 92–0023: 107.
   Google Scholar
• Thomson JPS, Grace RH. The treatment of perianal and anal condylomata. J R Soc Med 1978; 71: 180–5.
   PubMed Web of Science ®Google Scholar
• Duus BR, Philip sen T, Christensen JD, et al. Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treat-ment. Genitourin Med 1985; 61: 59–61.
   PubMedGoogle Scholar
• Gollock JM, Slatford K, Hunter IM. Scissor excision of anogenital warts. Br J Vener Dis 1982; 58: 400–1.
   PubMedGoogle Scholar
• Simmons PD, Thomson JPS. Scissors excision of penile warts: case report. Genitourin Med 1986; 62: 277–8.
   PubMedGoogle Scholar
• Stanhope CR, Phibbs Gd, Stuart GC, Reid R. Carbon dioxide laser surgery. Obstet Gynecol 1983; 61: 624–7.
   PubMed Web of Science ®Google Scholar
• Townsend DE, Levine RU, Crum DP, Richart RM. Treatment of vaginal carcinoma in situ with the carbon dioxide laser. Am J Obstet Gynecol 1982; 143: 546–7.
   Web of Science ®Google Scholar
• Ferenczy A. Laser therapy of genital condylomata acuminata. Obstet Gynecol 1984; 63: 703–7.
   PubMed Web of Science ®Google Scholar
• Kaufman RH, Friedrich EG. The carbon dioxide laser in the treatment of vulvar disease. Clin Obstet Gynecol 1985; 28: 220–8.
   PubMed Web of Science ®Google Scholar
• Landthaler M, Haina D, Brunner R, Waidelich W, Braun-Falco O. Laser therapy of bowenoid papulosis and Bowen's disease. J Derm Surg Oncol 1986; 12: 1253–7.
   PubMedGoogle Scholar
• Bar-Am, Shilon M, Peyser MR, Ophir J, Brenner S. Treatment of male genital condylomatous lesions by carbon dioxide laser after failure of previous nonlaser methods. J Am Acad Dermatol 1991; 24: 87–89.
   Google Scholar
• Duus BR, Philipsen T, Christensen JD, et al. Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treat-ment. Genitourin Med 1985; 61: 59–61. Scand J Urol Nephrol Suppl 205
   PubMedGoogle Scholar
• Stein BS. Laser treatment of condylomata acuminata. J Urol 1986; 136: 593–4.
   PubMed Web of Science ®Google Scholar
• Krogh J, Beuke H-P, Miskowiak J, de Lichtenberg H, Nielsen OS. Long-term results of carbon dioxide laser treatment of meatal condylomata acuminata. Br J Urol 1990; 65: 621–3.
   Google Scholar
• Bahmer FA, Tang DE, Payeur-Kirsch M. Treatment of large condylomata of the penis with the neodymium-YAG laser. Acta Derm Venereol 1984; 64: 631–3.
   Google Scholar
• Baggish MS. Improved laser techniques for the elimination of genital and extragenital warts. Am J Obstet Gynecol 1985; 153: 545–50.
   PubMed Web of Science ®Google Scholar
• Schilling A, Teufel KJ, Friesen A, Hofstetter A. Treatment of condylomata acuminata in the penile and bulbous portions of the urethra with neodymium-YAG laser: a new technique. Dtsch Med Wochenschr 1984; 126: 1116–8.
   Google Scholar
• Graverson PH, Bagi P. Rosenkilde P. Laser treatment of recurrent urethral condylomata acuminata in men. Scand J Urol Nephrol 1990; 24: 163.
   PubMedGoogle Scholar
• Hrebinko RL. Severe injury from neodynium: yttrium-aluminum-garnet laser therapy for penile condylomata acuminata. Urology 1996; 48: 155–6.
   PubMed Web of Science ®Google Scholar
• Cox NH, Eedy DJ, Morton CA. Guidelines for manage-ment of Bowen's disease. Br J Dermatol 1999; 141: 633–41.
   Google Scholar
• Krebs HB. Genital HPV infections in men. Clin Obstet Gynecol. 1989; 32: 180–90.
   PubMed Web of Science ®Google Scholar
• Simmons PD, Langlet F, Thin RN. Cryotherapy versus electrocautery in the treatment of genital warts. Br J Vener Dis 1981; 57: 273–4.
   PubMedGoogle Scholar
• Bissada NK. Conservative extirpative treatment of cancer of the penis. Urol Clin N Am 1992; 19: 283–90.
   PubMed Web of Science ®Google Scholar
• Graham JH, Helwig EB. Erythroplasia of Queyrat. A clinicopathologic and histochemical study. Cancer 1973; 32: 1396–414.
   Google Scholar
• Mohs FE, Snow SN, Larson PO. Mohs micrographic surgery for penile tumors. Urol Clin N Am 1992; 19: 291–304.
   PubMed Web of Science ®Google Scholar
• Moritz DL, Lynch WS. Extensive Bowen's disease of the penile shaft treated with fresh tissue Mohs micro-graphic surgery in two separate operations. J Dermatol Surg Oncol 1991; 17: 374–8.
   PubMedGoogle Scholar
• Boon TA. Sapphire probe laser surgery for localized carcinoma of the penis. Eur J Surg Oncol 1988; 14: 193–5.
   PubMed Web of Science ®Google Scholar
• Thestrup-Pedersen K, Ravnborg L, Reymann F. Morbus Bowen. Acta Derm Venereol 1988; 68: 236–9.
   PubMed Web of Science ®Google Scholar
• Veien SK, Veien NK, Hattel T, Laurberg G. Results of treatment of non-melanoma skin cancer in dermatologic practice. A prospective study. Ugeskrift Laeger 1996; 158: 7213–5.
   PubMedGoogle Scholar
• Gerber GS. Carcinoma in situ of the penis. J Urol 1994; 15: 829–33.
   Web of Science ®Google Scholar
• Malloy TR, Wein AJ, Carpiniello VL. Carcinoma of penis treated with neodymium YAG laser. Urology 1988; 31: 26–9.
   Google Scholar
• Tietjen DN, Malek RS. Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology 1998; 52: 559–65.
   PubMed Web of Science ®Google Scholar
• Pyrhonen S, Maiche AG, Mantyjarvi R. Verrucous carcinoma of the penis successfully treated with inter-feron. Br J Urol 1991; 68: 102–4.
   Google Scholar
• Maiche AG, Pyrhonen S. Verrucous carcinoma of the penis: three cases treated with interferon-alpha. Br J Urol 1997; 79: 481–3.
   PubMedGoogle Scholar
• Cardamakis E, Relakis K, Ginopoulos P. et al. Treatment of penile intraepithelial neoplasia (PIN) with interferon alpha-2a, CO2 laser (vaporization) and 5-fluorouracil 5% (5-FU). Eur J Gynaecol Oncol 1997; 18: 410–3.
   Google Scholar
• August PJ, Milward TM. Cryosurgery in the treatment of lichen sclerosus et atrophicus of the vulva. Br J Dermatol 1980; 103: 667–70.
   PubMed Web of Science ®Google Scholar
• Kaufman RH, Friedrich EG. The carbon dioxide laser in the treatment of vulva disease. J Obst Gynecol 1985; 28: 220–8.
   Google Scholar
• Ratz JL. The carbon dioxide laser treatment of balanitis xerotica obliterans. J Am Acad Dermatol 1984; 10: 925–8.
   PubMed Web of Science ®Google Scholar
• Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J Dermatol 1997; 136: 356–9.
   PubMed Web of Science ®Google Scholar
• Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1994; 46: 53–6.
   PubMed Web of Science ®Google Scholar
• Cattaneo A, Carli P. De Marco A, Sonni L, Bracco G, De Magnis A, et al. Testosterone maintenenance therapy: effects on vulvar lichen sclerosus treated with clobetasol propionate. J Reprod Med 1996; 41: 99–102.
   Google Scholar
• Daziel KL, Millard PR, Wojnarowska F. The treatment of vulvar lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol 1991; 124: 461–4.
   Google Scholar
• Daziel L, Wojnarowska F. Long-term control of vulvar lichen sclerosus after treatment with a potent topical steroid cream. J Reprod Med 1993; 38: 25–7.
   PubMed Web of Science ®Google Scholar
• Lau PWY, Cook N, Andrews H, Bracke H, Myint H. Detection of human papillomavirus types in balanitis xerotica obliterans and other penile conditions. Geni-tourin Med 1995; 71: 228–30.
   Google Scholar
• Khare S, Pater MP, Tang S-C, Pater A. Effect of glucocorticoid hormones on viral gene expression, growth and dysplastic differentiation in HPV 16-immortilized ectocervical cells. Exp Cell Res 1997; 232: 253–60.
   Google Scholar
• Friedman M, Weissman A, Kerner H, Itskovitz Eldor I. Vulvar lichen sclerosus treated with superpotent topical corticosteroid (clobetasol propionate 0.05%). Cervix 1994; 12: 21–4.
   Google Scholar
• Dahlman-Ghozlan K, Hedblad M-A, von Krogh G. Penile lichen sclerosus et atrophicus treated with cl6obetasol dipropionate 0.05% cream: a retrospective clinical and histopathologic study. J Am Acad Dermatol 1999; 40: 451–7.
   Google Scholar
• Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353: 1177–83.
   Web of Science ®Google Scholar
• Krebs HB. Genital HPV infections in men. Clin Obstet Gynecol 1989; 32: 180–90.
   PubMed Web of Science ®Google Scholar
• Ferenczy A, Kohn MD, Shore M. Evaluating male partners of condyloma patients. Contemp Obstet Gyne-col 1983: 183.
   Google Scholar
• Oriel JD. Sexually transmitted diseases in children: human papillomavirus infection. Genitourin Med 1992; 68: 80–3.
   PubMedGoogle Scholar
• Aynaud O, Ionesco M, Barrasso R. Penile intraepithelial neoplasia. Specific clinical features correlate with histologic and virologic findings. Cancer 1994; 74: 1762–7.
   Google Scholar
• Barrasso R, DeBrux J, Croissant O, Orth G. High prevalence of papillomavirus-associated penile intraepi-thelial neoplasia of the sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med 1987; 317: 916–23.
   PubMed Web of Science ®Google Scholar
• Maymon R, Shulman A, Maymon B, Bekerman A, Werchow M, Faktor JH, et al. Penile condylomata: a gynecological epidemic disease: a review of the current approach and management aspects. Obstet Gynecol Surv 1994; 49: 790–800.
   PubMedGoogle Scholar
• Malek RS, Goellner JR, Smith TF, Espy MJ, Cupp MR Urology 1993; 42: 159–70.
   PubMed Web of Science ®Google Scholar
• Felix JC, Wright TC. Analysis of lower genital tract lesions clinically suspicious for condylomata using in situ hybridization and the polymerase chain reaction for the detection of human papillomavirus. Arch Pathol Lab Med 1994; 118: 39–43.
   PubMed Web of Science ®Google Scholar
• Krebs H-B, Helmkamp BF. Does the treatment of genital condylomata in men decrease the treatment failure rate of cervical dysplasia in the female sexual partner? Obstet Gynecol 1990; 76: 660–3.
   Google Scholar
• Ward BG, Thomas IL. Randomized prospective inter-vention study of human cervical wart virus infection. Aust NZ J Gynaecol 1994; 34: 182–5.
   PubMed Web of Science ®Google Scholar